Buyer Takeaway: an operating business with published policies isn't the same thing as independent proof of outcomes - the difference matters most for exactly the details you'd want confirmed before paying
He hoped to sell higher volumes of obesity and diabetes drugs over the coming years, saying: We are seeing a volume response to lower prices. He pointed to Novos agreement with the Trump administration to cut prices heavily, from more than $1,000 a month (730) to an average price of $350 (255), and the patent expiry of semaglutide, the main ingredient of its obesity and diabetes drugs, in several countries including India
For a complete overview of retatrutide side effects and management strategies, see our complete side effects guide
For vaginal complaints, a pragmatic approach consistent with pharmacovigilance principles is: Continue semaglutide while treating common causes unless symptoms are severe, refractory, temporally tightly linked to dosing/escalation, and alternative diagnoses have been reasonably excluded